Evaluation of NID2 promoter methylation for screening of Oral squamous cell carcinoma

BACKGROUND: Oral squamous cell carcinoma (OSCC) is an aggressive human malignancy. Because of late diagnosis and recurrence of OSCC, the treatment of patients with OSCC is often ineffective. Thus, finding novel biomarkers of OSCC are essential. Here we derived a methylation marker by utilizing methy...

Descripción completa

Detalles Bibliográficos
Autores principales: Srisuttee, Ratakorn, Arayataweegool, Areeya, Mahattanasakul, Patnarin, Tangjaturonrasme, Napadon, Kerekhanjanarong, Virachai, Keelawat, Somboon, Mutirangura, Apiwat, Kitkumthorn, Nakarin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071563/
https://www.ncbi.nlm.nih.gov/pubmed/32171289
http://dx.doi.org/10.1186/s12885-020-6692-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7071563/
https://www.ncbi.nlm.nih.gov/pubmed/32171289
http://dx.doi.org/10.1186/s12885-020-6692-z

Ejemplares similares